Last reviewed · How we verify

NCT03270215

The Added Value of CT Scanning in Patients With an Unilateral Pleural Effusion

Completed Last updated 17 December 2020
What this trial tests

trial testing Computed tomography in Pleural Effusion, Malignant in 232 participants. Completed in 30 January 2019.

Timeline
1 October 2017
Primary endpoint
31 January 2018
30 January 2019

Quick facts

Lead sponsorNaestved Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment232
Start date1 October 2017
Primary completion31 January 2018
Estimated completion30 January 2019
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

Naestved Hospital

Who can join

16 and older, any sex, with Pleural Effusion, Malignant. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To investigate the diagnostic power of computed tomography for discriminating malignant from nonmalignant causes to pleural effusions in consecutive patients with no malignant cells found at a cytological examination and a chest x-ray not suspicious of malignancy. The investigators hypothesised that the combination improves the chance of detecting the cause of the pleural effusion.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Computed tomography

Trials testing the same drug.

Other recruiting trials for Pleural Effusion, Malignant

Currently open trials in the same condition.

Other Naestved Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03270215.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing